Follow the 株式会社冨田医療研究所 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社冨田医療研究所 has logged 1 reports. The latest transaction was filed on 2 December 2021 (Holding update). All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Tomiita Medical Research Institute is a Japanese company focused on the research and development of medical solutions. It primarily operates in the healthcare and pharmaceutical sector.